ATTENTION KROS SHAREHOLDERS: Investors who lost money on Keros Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Keros Therapeutics, Inc. for potential federal securities law violations. This follows Keros' announcement of halting certain treatment arms in a clinical trial due to safety concerns.
December 18, 2024 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Keros Therapeutics is under investigation for potential securities law violations after halting parts of a clinical trial due to safety concerns. This could impact investor confidence and stock price.
The investigation by Levi & Korsinsky into Keros Therapeutics for potential securities law violations, combined with the halting of a clinical trial due to safety concerns, is likely to negatively impact investor confidence and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100